Megan Dacek - Immunai | 人才画像

基本信息

Career Trajectory

Bio

Megan Dacek earned her PhD from Weill Cornell Medicine in April 2021, studying novel strategies to improve CAR T cell therapy. She studied under Dr. David A Scheinberg (MSKCC). Megan is currently a Scientist at Immunai, engineering next generation CAR T cells.

Research Interests

Papers共 21 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Engineering CAR-T Cells for Radiohapten Capture in Imaging and Radioimmunotherapy Applications

THERANOSTICSno. 15 (2023): 5469-5482

Cited5Views0WOSBibtex

Supplementary Data from ALK and RET Inhibitors Promote HLA Class I Antigen Presentation and Unmask New Antigens Within the Tumor Immunopeptidome

Claire Y. Oh,Martin G. Klatt,Christopher Bourne,Tao Dao,Megan M. Dacek,Elliott J. Brea,Sung Soo Mun,Aaron Y. Chang,Tatyana Korontsvit,David A. Scheinberg

openalex（2023）

Cited0Views0Bibtex

Supplementary Data from A PET Imaging Strategy for Interrogating Target Engagement and Oncogene Status in Pancreatic Cancer

Kelly E. Henry,Megan M. Dacek,Thomas R. Dilling,Jonathan D. Caen,Ian L. Fox, Michael J. Evans,Jason S. Lewis

openalex（2023）

Cited0Views0Bibtex

Host Interactions with Engineered T-cell Micropharmacies

Christopher M. Bourne,Patrick Wallisch,Megan M. Dacek,Thomas J. Gardner,Stephanie Pierre,Kristen Vogt,Broderick C. Corless, Mamadou A. Bah,Jesus E. Romero-Pichardo,Angel Charles,Keifer G. Kurtz,Derek S. Tan,David A. Scheinberg

CANCER IMMUNOLOGY RESEARCH（2023）

Cited1Views0WOSBibtex

Supplementary Figures from Host Interactions with Engineered T-cell Micropharmacies

openalex（2023）

Cited0Views0Bibtex

Potentiating Antibody-Dependent Killing of Cancers with CAR T Cells Secreting CD47-SIRPα Checkpoint Blocker

Megan M. Dacek,Keifer G. Kurtz,Patrick Wallisch,Stephanie A. Pierre,Shireen Khayat,Christopher M. Bourne,Thomas J. Gardner,Kristen C. Vogt,Nica Aquino,Anas Younes,David A. Scheinberg

BLOODno. 16 (2023): 2003-2015

Cited13Views0WOSBibtex

A TCR Mimic CAR T Cell Specific for NDC80 is Broadly Reactive with Solid Tumors and Hematologic Malignancies

Martin G. Klatt,Tao Dao,Zhiyuan Yang,Jianying Liu,Sung Soo Mun,Megan M. Dacek,Hanzhi Luo,Thomas J. Gardner,Christopher Bourne,Leila Peraro,Zita E. H. Aretz,Tanya Korontsvit, Michael Lau,Michael G. Kharas,Cheng Liu,David A. Scheinberg

Blood（2022）

Cited13Views0WOSBibtex

Engineering CAR-T Cells to Activate Small-Molecule Drugs in Situ

Thomas J. Gardner, J. Peter Lee,Christopher M. Bourne,Dinali Wijewarnasuriya,Nihar Kinarivala,Keifer G. Kurtz,Broderick C. Corless,Megan M. Dacek,Aaron Y. Chang,George Mo, Kha M. Nguyen,Renier J. Brentjens,Derek S. Tan,David A. Scheinberg

Nature Chemical Biology（2021）

Cited47Views0WOSNATUREBibtex

CT-080: A Tumor-Agnostic TCR-Mimic CAR-T Cell Specific for NDC80 Targets Multiple Hematological Malignancies

Martin G. Klatt,Tao Dao,Zhiyuan Yang,Jianying Liu,Sung Soo Mun,Megan M. Dacek,Hanzhi Luo,Thomas J. Gardner,Christopher Bourne,Leila Peraro,Zita E.H. Aretz,Tanya Korontsvit,Michael G. Kharas,Cheng Liu,David A. Scheinberg

Clinical Lymphoma Myeloma & Leukemia (2021): S257-S257

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn